Open Access

[Corrigendum] Resveratrol reverses P‑glycoprotein‑mediated multidrug resistance of U2OS/ADR cells by suppressing the activation of the NF‑κB and p38 MAPK signaling pathways

  • Authors:
    • Rui Zhang
    • Ming Lu
    • Zhen Zhang
    • Xiliang Tian
    • Shouyu Wang
    • Decheng Lv
  • View Affiliations

  • Published online on: January 10, 2024     https://doi.org/10.3892/ol.2024.14225
  • Article Number: 92
  • Copyright : © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

March-2024
Volume 27 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang R, Lu M, Zhang Z, Tian X, Wang S and Lv D: [Corrigendum] Resveratrol reverses P‑glycoprotein‑mediated multidrug resistance of U2OS/ADR cells by suppressing the activation of the NF‑κB and p38 MAPK signaling pathways. Oncol Lett 27: 92, 2024
APA
Zhang, R., Lu, M., Zhang, Z., Tian, X., Wang, S., & Lv, D. (2024). [Corrigendum] Resveratrol reverses P‑glycoprotein‑mediated multidrug resistance of U2OS/ADR cells by suppressing the activation of the NF‑κB and p38 MAPK signaling pathways. Oncology Letters, 27, 92. https://doi.org/10.3892/ol.2024.14225
MLA
Zhang, R., Lu, M., Zhang, Z., Tian, X., Wang, S., Lv, D."[Corrigendum] Resveratrol reverses P‑glycoprotein‑mediated multidrug resistance of U2OS/ADR cells by suppressing the activation of the NF‑κB and p38 MAPK signaling pathways". Oncology Letters 27.3 (2024): 92.
Chicago
Zhang, R., Lu, M., Zhang, Z., Tian, X., Wang, S., Lv, D."[Corrigendum] Resveratrol reverses P‑glycoprotein‑mediated multidrug resistance of U2OS/ADR cells by suppressing the activation of the NF‑κB and p38 MAPK signaling pathways". Oncology Letters 27, no. 3 (2024): 92. https://doi.org/10.3892/ol.2024.14225